CM363, a novel naphthoquinone derivative which acts as multikinase modulator and overcomes imatinib resistance in chronic myelogenous leukemiaBorja Guerra, Leandro Fernández‐Pérez|Oncotarget|2016Cited by 13
A Novel Naphthoquinone-Coumarin Hybrid That Inhibits BCR-ABL1-STAT5 Oncogenic Pathway and Reduces Survival in Imatinib-Resistant Chronic Myelogenous Leukemia CellsPatricia Martin‐Rodríguez, Leandro Fernández‐Pérez|Frontiers in Pharmacology|2019Cited by 12